Research on the liver in health and disease. Covers liver-disease subtypes, the liver's role in circadian timing, targeted therapies, and cell regulation.
Researchers found that hospital mortality increased significantly according to the Child-Pugh classification, with a mortality rate of 10 percent for those with class A, 18 percent for those with class B, and 67 percent for those with class C. Postoperative complications were also higher in class B and C than in class A.
Rimonabant reduces liver damage markers, decreases pro-inflammatory proteins, and improves lipid profiles in obese rats. It also normalizes levels of adiponectin, a hormone involved in metabolic disorders.
A new study analyzed predictors of sustained virologic response (SVR) in patients with hepatitis C virus (HCV) infection. The results identified several independent factors that impact SVR, including low levels of HCV in the blood, absence of cirrhosis, and genotype other than genotype 1. Patients treated with pegylated interferon alfa...
A recent study suggests that people with high cholesterol levels may be more susceptible to severe cases of tick-borne disease. The study found that bacteria levels were 10 times greater in mice with high cholesterol, indicating a potential link between cholesterol and disease severity.
Researchers at St. Jude Children's Research Hospital discovered how a single molecular switch triggers gene activity, affecting learning, memory and glucose production in the liver. The study shows that genes choose their co-factors, requiring a more complex view of CREB's function.
Scientists discovered that ezetimibe targets NPC1L1 protein in both the intestine and liver, lowering cholesterol levels by blocking absorption. This dual action may increase the risk of gallstones, highlighting the need for further research.
Researchers found that TRAIL limits inflammation and brain cell death in bacterial meningitis by regulating the host immune response. In contrast, mice lacking TRAIL exhibited increased inflammation and brain cell death, which was reversed by administering recombinant TRAIL.
Researchers at the University of Pennsylvania School of Medicine have discovered a potential new target for treating type 2 diabetes, a protein that regulates fat metabolism. The study found that insulin stimulates the addition of a phosphate group to this protein, preventing the activation of genes involved in fat metabolism.
Researchers at Beth Israel Deaconess Medical Center have identified a key mechanism behind the turn of events when high-fat, low-carbohydrate diets cause demonstrable changes in metabolism and subsequent weight loss. FGF21, a liver hormone, is required to oxidize fatty acids and burn calories.
Researchers have identified a new 'starvation hormone' that plays a critical role in the metabolic shift seen in animals on low-carb, high-fat diets. Increased levels of liver-derived FGF21 hormone are required for mice to switch gears and begin burning fat.
A recent study published in Liver Transplantation found that more than 78 percent of living right liver donors experienced post-operative complications, with most being minor but some life-threatening. The modified Clavien system was used to classify the severity of complications, with Grade I being minor and Grade V resulting in death.
The co-infection of HIV and viral hepatitis is a growing concern, with recent studies showing increasing rates of liver disease and related deaths among those with HIV. Hepatologists are discussing the best approaches to treating these patients, including the use of new agents and consideration of liver transplantation.
A study by Arlette Darfeuille-Michaud and colleagues reveals that CEACAM6 expression promotes adherent-invasive E. coli's colonization in intestinal epithelial cells of patients with Crohn's disease, indicating a potential diagnostic marker for the condition. Meanwhile, another study by Andrea Hevener and colleagues shows that macropha...
Saint Louis University research found that a diet of 40% fat and high-fructose corn syrup leads to fatty liver disease and type II diabetes, even in sedentary mice
Researchers found that adult men and postmenopausal women require significantly higher amounts of choline to prevent fatty liver and muscle damage. Eggs are an excellent source of this essential nutrient, providing nearly half the recommended daily supply per serving.
Researchers at Mayo Clinic have developed a new imaging technique called magnetic resonance elastography (MRE) to diagnose liver diseases. MRE accurately measures the hardness or elasticity of the liver, enabling non-invasive diagnosis of fibrosis and cirrhosis.
Researchers at VCU Medical Center report nearly all patients with hepatitis C treated successfully have no detectable virus after seven years. The study validates the use of 'cure' to describe successful treatment, offering hope for those affected by the disease.
Researchers found that statin therapy improved ALT values in chronic hepatitis C patients with abnormal liver enzymes. The study also showed a higher sustained viral response rate when adding statins to standard peginterferon and ribavirin treatment, suggesting a possible new treatment option.
Researchers have made significant advancements in diagnosing and treating chronic hepatitis C, with potential new markers for detecting liver cancer. Studies have also explored the role of autotaxin in linking hepatitis C to hepatocellular carcinoma.
Researchers introduce novel methods for evaluating patients with non-alcoholic fatty liver disease (NAFLD), including a blood test to determine caspase three-generated cytokeratin 18 fragment levels. These tests may help differentiate NASH from simple steatosis and predict treatment outcomes, potentially improving patient care.
New research explores liver biomarkers, disease complications, and novel treatments to improve outcomes in patients with liver disease. A study found that an elevated ALT/AST ratio can predict coronary atherosclerosis in women, independent of metabolic syndrome.
A recent study found that CT and MRI are highly accurate in determining optimal candidates for liver transplantation in patients with cirrhosis. The study demonstrated agreement between radiology and pathology staging in 96.5-97.5% of patients, supporting the use of imaging tools in candidate selection.
Contrast-enhanced ultrasound (CE-US) is highly accurate in identifying vascular and biliary complications after liver transplant, affecting up to 43.5% of patients. CE-US can accurately detect complications such as hepatic artery thrombosis, portal vein stenosis, and bile leaks.
A study of HCV patients post-liver transplantation reveals stagnant survival rates, contrasting with improving outcomes for non-HCV recipients. Researchers analyzed a large sample of US liver transplant data between 1991 and 2001, finding HCV patients had lower 3-year survival rates and no improvement in survival over time.
A study of hospitalized patients with cirrhosis and complications of portal hypertension reveals significant racial disparities in treatment, with African-American and Hispanic patients less likely to receive palliative shunts, liver transplants, and prompt endoscopy. These disparities were independent of health insurance status.
A study found that liver stiffness measurement by transient elastography can predict severe portal hypertension in patients with hepatitis C-related cirrhosis. The technique is less invasive than traditional methods like HVPG measurement and shows promise for non-invasive diagnosis.
Researchers found that rats fed tart cherries had lower cholesterol, blood sugar, fat storage in the liver, oxidative stress, and improved fat handling. The study suggests a potential benefit from anthocyanin-rich foods like tart cherries for heart disease and diabetes prevention.
A recent study has established a significant correlation between bile duct obstruction and the growth rate of bile duct cancer cells in animals. In fact, cancer cells in obstructed bile ducts grew up to five times faster than those without obstruction, leading to increased metastasis outside the liver.
Researchers have developed a genetic test that can predict which hepatitis C patients are at high risk of developing cirrhosis. The test uses a 'Cirrhosis Risk Score' based on seven genes and has been validated in independent studies, offering hope for more targeted treatment.
Hepatitis A and C viruses attack the same protein, MAVS, to block immune defenses, allowing them to survive in the liver. This discovery provides a new perspective on the chronicity of hepatitis C, a highly relevant virus clinically.
Researchers have discovered that liver regeneration is driven by an increase in cell multiplication through regular cell divisions, rather than relying on embryonic-like processes. This finding could lead to more effective ways to stimulate liver growth and potentially improve treatment options for patients with liver diseases.
A 4-step process can be completed quickly and efficiently to assess potential living liver donors. Despite challenges, the process results in a significant proportion of donors undergoing successful transplantation, emphasizing the importance of careful workup and informed consent.
Researchers developed a non-invasive method to predict advanced fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) using routine clinical and laboratory values. The study found that age, hyperglycemia, body mass index, platelet count, albumin, and AST/ALT ratio were independent indicators of advanced liver fibrosis.
Scientists have identified a protein that excretes ammonia through pufferfish gills as similar to human Rh blood proteins, offering hope for people with liver and kidney disease. Targeting Rh proteins could lead to new treatments for removing toxic ammonia from the bloodstream.
Researchers at UCSD School of Medicine discovered a cellular receptor involved in triggering cell death is also necessary for tissue repair and regeneration after liver injury. p75 neurotrophin receptor promotes the initial activation of hepatic stellate cells to stimulate new hepatic cell proliferation.
Using adult bone marrow stem cells, researchers successfully regenerated healthy liver tissue in patients, doubling the liver growth rate and allowing for earlier surgical resection. This therapy has potential as a treatment for regenerating livers damaged by other chronic and acute diseases.
Researchers found simultaneous surgeries on colon and liver may reduce length of hospital stay and surgical complications without compromising long-term survival. In certain patient groups, simultaneous surgery was as safe as separate surgeries, potentially leading to better outcomes.
The study found that survival rates for patients with hepatitis B who need liver transplants are similar between those with and without hepatocellular carcinoma (HCC). Despite the higher likelihood of transplantation, 5-year survival rates were comparable between the two groups. The findings suggest that antiviral therapy may have bene...
Research suggests sweat can carry hepatitis B virus, potentially transmitting the infection during contact sports. The study found that 13% of Olympic wrestlers had hidden or occult HBV infection and 11% had particles of the virus in their sweat.
The Model for End-Stage Liver Disease (MELD) is an accurate predictor of liver disease survival, particularly useful in allocating organs for transplants. However, efforts to refine its accuracy are needed to further improve patient outcomes.
A study found that lactulose improved cognitive function and health-related quality-of-life in patients with minimal hepatic encephalopathy, a condition associated with advanced liver disease. The treatment showed significant improvement in emotional behavior, movement, mobility, sleep/rest, and recreational activities.
Researchers have identified the liver as a promising target for cancer gene therapy using viral vectors, taking advantage of the structural disorganization in cancer cells. The study demonstrates that adenoviral vectors can selectively infect cancer cells while leaving normal liver cells unharmed.
A 15-year study on liver retransplantation found positive trends in indications for surgery, fewer rejections and complications, and improved intensive care management. Therapeutic measures such as immunosuppressant dosage reduction and early blood transfusions contributed to better patient survival rates.
A new study found that a series of simple blood tests can accurately diagnose liver fibrosis in patients with chronic hepatitis C. The FibroIndex was more accurate than two other indices and showed promise as a non-invasive alternative to liver biopsy.
Researchers studying mice and rats found that CLA supplementation led to rapid weight loss in mice but excessive liver fat accumulation, a common side effect of rapid weight loss. In contrast, rats on a CLA-supplemented diet showed decreased insulin resistance despite not losing weight.
A novel transgenic mouse model shows that the circadian liver clock can drive gene expression in the absence of systemic cues, while systemic cues can also synchronize peripheral clocks. This suggests a complex interplay between local and systemic control mechanisms.
A new study has found that the ADH1B*3 allele appears to protect against alcoholism in Afro-Trinidadians, while increasing the risk for liver disease among those who drink heavily. Individuals with this allele have lower alcohol consumption levels and are less likely to be alcohol-dependent.
Critically ill patients receiving early enteral nutrition had lower rates of liver dysfunction compared to those fed through central venous catheters. Early feeding was associated with reduced liver dysfunction, longer ICU stays, but no increased mortality.
A study found that liver transplant patients with a history of obesity, impaired fasting glucose, and hepatitis C infection are at increased risk of developing new-onset diabetes mellitus. The risk factors also include the use of certain immunosuppressants and cardiovascular risk factors.
Studies found that heparan sulfate in the liver plays a crucial role in clearing triglycerides and cholesterol from the blood. The discovery could lead to new treatments for high blood-fat levels and related complications such as arthrosclerosis.
Researchers have identified a new 'glucose sensor' that plays a crucial role in glucose metabolism and fat synthesis, potentially leading to new treatments for obesity and diabetes. The discovery highlights the significance of the Liver X Receptors (LXRs) in regulating gene expression linked to cholesterol and fat metabolism.
A novel compound, tazopsine, isolated from a Madagascan plant has shown activity against the liver stages of human and mouse malaria. Its semisynthetic derivative, NCP-tazopsine, completely protected mice from malaria parasites, suggesting a promising new candidate for anti-malarial prophylaxis.
Researchers have developed a gene chip that can detect genetic causes of jaundice in children and adults, potentially leading to personalized treatment options. The 'jaundice chip' is nearly 100% effective in detecting common mutations associated with inherited liver diseases.
Researchers at Rice University and The University of Texas M. D. Anderson Cancer Center found that carbon nanotubes injected into lab animals cause no immediate harm and circulate in the blood and liver for over an hour before being eliminated. The study provides promising results for biomedical applications of carbon nanotubes.
Research on mice carrying a mutated human gene for alpha-1-antitrypsin deficiency found that a non-steroidal anti-inflammatory drug significantly increased liver damage. The study suggests that NSAIDs could exacerbate liver injury in people with alpha-1-AT deficiency, highlighting the need to avoid these drugs.
Researchers developed a new model to predict survival after liver transplantation, considering specific characteristics of donors and recipients. The model identified key factors impacting graft survival, including donor age and recipient MELD score.
Researchers discovered that liver cells can activate T cells independently of the lymph system, potentially contributing to impaired immune responses in chronic hepatitis C. The study found that T cells interact with liver cells through fenestrations in sinusoidal endothelial cells.
Researchers used resveratrol to increase the lifespan of obese mice, reversing nearly all changes in gene expression patterns linked to diabetes and heart disease. The study also found improved motor skills and quality of life in mice treated with resveratrol, suggesting potential therapeutic applications for age-related diseases.
A study by the NIH/National Institute on Aging demonstrates that resveratrol, an activator of sirtuins, can improve health and survival in aged overweight male mice. Resveratrol supplementation improved insulin sensitivity, reduced liver size, and enhanced motor function in the mice compared to those without resveratrol.
A new study by Saint Louis University researchers shows a cocktail of ribavirin and Infergen is nearly twice as effective in controlling hepatitis C than standard treatments. Fourteen percent of patients taking the treatment were virus-negative after six months.